Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    FDA To Host Public Hearing On Manufacturer Communications Regarding Unapproved Uses Of Medical Products

    On November 9 and 10, 2016, the Food and Drug Administration (FDA) is hosting a public hearing on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    FDA Updates Guidance Documents For Product-Specific Bioequivalence Recommendations

    A complete list of active ingredients and links to the recommendations for each can be found on FDAs website.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
Jones Day
  • Article

    FDA Withdraws Proposed Effective Date Of Requirement For Premarket Approval For Cranial Electrotherapy Stimulator Devices

    FDA withdrew the proposed rule and proposed order after reviewing information received in response to the proposals.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA,OHRP Considering Guidance On Use Of Electronic Informed Consent In Clinical Investigations

    As discussed on our sister blog, Life Sciences Legal Update, the FDA has published a notice soliciting comments on a draft guidance document on the use of electronic media and processes to obtain informed consent for FDA-regulated clinical investigations of medical products.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Final Rule On Amending The Anti-Kickback Safe Harbors And Civil Monetary Penalty Rules On Beneficiary Inducements

    The rule finalizes, with certain modifications, all of the AKS safe harbors and beneficiary inducement CMP exceptions noted in a proposed rule published on October 3, 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Fourth Circuit Dismisses False Claims Act Case Based On FDA cGMP Violations

    Reed Smith Partner Larry Sher authored a post on the Drug and Device Law Blog about a recent decision in which the U.S. Court of Appeals for the Fourth Circuit affirmed the dismissal of a False Claims Act ("FCA") case brought against ..
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Generics Association Raises Concerns About Misuse Of REMS Program

    In the past, the Federal Trade Commission has expressed similar concerns about the potentially anticompetitive misuse of REMS plans.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Incentives To Repurpose Existing Drugs For Orphan Indications

    This article discusses the Orphan Drug Act and its success in providing incentives to find cures for orphan diseases, ..
    United StatesFood, Drugs, Healthcare, Life Sciences
    Venable LLP
    Venable LLP
  • Article

    Interchangeable Biosimilars – Emerging Legal Issues And Trends

    Goodwin is a proud sponsor of the conference and partner Brian Burgess is a featured speaker on the panel, Interchangeable Biosimilars – Emerging Legal Issues and Trends.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    International Biosimilar Approval And Launch Updates

    Earlier this month, Samsung Bioepis Co. Ltd. announced that Health Canada approved ONTRUZANT (also known as SB3), a biosimilar referencing Herceptin (Trastuzumab), for the treatment of adults with Early Breast Cancer...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    IP Strategies For Medical Device Technologies: Be Your Own Incubator

    The book is an essential resource for inventors, attorneys, IP professionals, or anyone with an interest in medical device IP for understanding the nuances of protecting and launching a medical...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Oblon
    Oblon
  • Article

    Janssen And Samsung Bioepis Settle STELARA (Ustekinumab) Litigation

    Samsung Bioepis recently reported that it has signed a settlement and license agreement with Johnson & Johnson ("J&J") in the United States relating to SB17, Samsung Bioepis's ustekinumab...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Medical Device Recalls Increased By 97% Over 10-Year Period

    The annual number of medical device recalls increased by 97 percent from fiscal year 2003 to fiscal year 2012.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Video

    MoCRA Featured On The Class Action Weekly Wire Podcast With Guest Kelly Bonner (Video)

    In Episode 35 of the Class Action Weekly Wire podcast, host Jerry Maatman interviews Duane Morris associate Kelly Bonner about the Modernization of Cosmetics Regulation Act (MoCRA).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Article

    Nanotech Basis For Fast DNA Sequencing

    Last week, it was exciting to prepare a talk on new developments in nanotechnology for the USPTO.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Nanotechnology Helps Create Real Life Version Of Harry Potter’s Invisibility Cloak

    Scientists at the University of Texas at Dallas may soon help Harry Potter fans everywhere realize their dreams.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Nanotechnology Sensors On The Surface Of Individual Biological Cells Will Improve The Understanding Of Cell Interaction In Medical And Pharmaceutical Research

    Nanotechnology researchers in Boston at the Center for Regenerative Therapeutics at Brigham and Women’s Hospital, known as ReGen Rx, have successfully engineered sensors onto the surface of individual biological cells using nanotechnology.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Neurosurgeons' Compensation In Top 10 Percent Nationwide Gives Rise To Stark Act And FCA Claims

    Then, by submitting false claims to Medicare and other federal health programs, the defendants knowingly or recklessly presented false claims for payment to the government in violation of the FCA.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    Next-Generation Biologics Market May Top $30 Billion By 2024

    An article in Pharma Manufacturing describes the tremendous growth potential for the next-generation biologics market, whose value could rise to $30 billion.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Orgenesis Strikes Deal With Columbia University To Develop Cellular Vaccination Product Platform

    Under the terms of the research pact, Orgenesis will receive an exclusive license on the technology developed at Columbia.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Pearl Cohen Zedek Latzer Baratz
    Pearl Cohen Zedek Latzer Baratz
  • Showing 281–300 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics